Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

Status Completed

Clinical Trial Summary

The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of uveitis.

Clinical Trial Description

The primary objective was to investigate the efficacy and safety of 0.05% difluprednate ophthalmic emulsion in patients with endogenous anterior uveitis and to determine its clinical usefulness for treatment of this disease in the early phase of development, in comparison with Rinderon® solution (containing 0.1% betamethasone sodium phosphate) that has widely been used for treatment of postoperative inflammation, uveitis, etc. as a steroid ophthalmic solution.

The secondary objective was to establish the evaluation system for a dose-finding study. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00405496
Study type	Interventional
Source	Sirion Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	March 2000
Completion date	April 2001

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00476593` - Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications	N/A
Recruiting	`NCT01486693` - Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis	N/A
Recruiting	`NCT01156285` - Acute Anterior Uveitis: Psychic Burden and Pain	N/A
Terminated	`NCT00333996` - A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis	Phase 2/Phase 3
Completed	`NCT02764697` - Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients	Phase 4
Completed	`NCT01376362` - Topical Interferon Gamma for Macular Edema Secondary to Uveitis	Phase 1/Phase 2
Recruiting	`NCT00407316` - Quality of Life and Visual Function in Uveitis Patients	Phase 0
Completed	`NCT02725177` - Ocular Sarcoidosis Open Label Trial of ACTHAR Gel	N/A
Completed	`NCT01647529` - Topical Administration of 0.15% Ganciclovir Gel for CMV Anterior Uveitis / Endotheliitis	N/A
Completed	`NCT00823173` - Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis	Phase 2
Completed	`NCT02517619` - Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis	Phase 3
Completed	`NCT01505088` - Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis	Phase 3
Completed	`NCT02879084` - Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis
Completed	`NCT02765308` - Aqueous Humor Dynamics and Hypertensive Uveitis	N/A
Completed	`NCT01154010` - PEMF: an Adjunct Therapy for Anterior Uveitis	N/A
Completed	`NCT00130637` - Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis	Phase 2
Completed	`NCT00406887` - Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis	Phase 3
Completed	`NCT00876434` - Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti	Phase 1